Tag: otcqb:rspi

February 10, 2017

RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for the treatment of respiratory disorders for which there...
January 6, 2017

RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for the treatment of respiratory disorders, particularly sleep apneas...
December 23, 2016

RespireRx Pharmaceuticals Inc. Announces Positive Results from Phase 2B PACE Study Conducted by the University of Illinois Dronabinol Reduces Symptoms of Obstructive Sleep Apnea

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) is pleased to announce positive results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement)...
December 15, 2016

RespireRx Pharmaceuticals Inc. Announces Data for CX1739 Clinical Study in Opioid Induced Respiratory Depression

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory...